Notice of AGM

RNS

For release: 11 November 2016

2016 Annual Report and AGM Notice

genedrive plc (LSE: GDR), the near patient molecular diagnostics company, gives notice that copies of its 2016 Annual Report and Notice of the 2016 Annual General Meeting have been posted to shareholders. The AGM will be held at 11.00am on Wednesday, 30 November 2016 at the the Company's premises at The Innovation Centre, 48 Grafton Street, Manchester M13 9XX.In 2015/16.

Copies of these documents may be found on the Company's website (www.genedriveplc.com)

.

- Ends -

For further details please contact:

genedrive plc

David Budd: CEO +44 (0)161 989 0245

John Rylands: Finance Director

Peel Hunt LLP

James Steel +44 (0)207 418 8900

Oliver Jackson

Consilium Strategic Communications

Chris Gardner +44 (0)203 709 5700

Matthew Neal

Laura Thornton

[email protected] 

Notes to Editors

genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need or point of care diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Genedrive® platform and MTB/RIF test have been launched in India and a Genedrive® HCV test has been successfully assessed by the Institut Pasteur, Paris.

genedrive plc was formerly Epistem plc and continues to provide contract research services to drug development companies under the Epistem brand name.

Further details can be found at: www.genedriveplc.com and www.genedrive.com